AVEXIA HEALTH AG

The company's purpose is to research, develop, manufacture, license, market and distribute medicines, both under its own brand names and original preparations. Furthermore, the company focuses on the distribution, consulting and prescription of medicines, dietary supplements and cosmetics through digital platforms and other distribution channels. In addition, the company is dedicated to the development and operation of digital health platforms and services. It particularly pursues the online distribution of medicines, dietary supplements and cosmetics and provides consulting and other services in the healthcare sector. The company can establish subsidiaries and branches in Switzerland and abroad, acquire, hold and sell real estate. The company can carry out all commercial, financial and other activities that are related to the company's purpose, as well as raise and invest funds on the money and capital markets. The company is part of a group of companies and can take into account the interests of this group when pursuing its corporate purpose. In particular, the company can grant loans and other direct or indirect financing to its direct and indirect subsidiaries and third parties, including its direct and indirect shareholders and their direct and indirect subsidiaries, including within the framework of cash pooling agreements, and provide security of all kinds for their liabilities, including by way of pledges on or fiduciary transfers of the company's assets or guarantees of any kind, whether remunerated or not.